ACTILLETS™ and TAP® Pellets – A Strong Start for Smarter Formulations
Our ACTILLETS™ microcrystalline cellulose (MCC) pellets offer low friability, high sphericity, and smooth surfaces — making coating consistent and reliable. And with TAP® tartaric acid pellets, you can boost the solubility of weakly basic APIs, unlocking new formulation possibilities.
TECHNOLOGY PARTNERSHIP
SPI Pharma’s ACTILLETS™ microcrystalline cellulose pellets and tartaric acid pellets combine our unique formulation and material science expertise with CELLETS® and TAP® pellet technology from ADD Advanced Drug Delivery Technology Ltd.
ADVANCED FORMULATION
SPI has expertise in developing excipient materials and in oral dose development, and we have combined this expertise with MCC and tartaric acid spheres that have superior physical properties.
SPI is a leader in technologies focused to pediatric or patient-friendly dose forms. ACTILLETS™ and TAP® pellet technology offer a promising solution for the development of oral drug formulations that require precise control over drug release and dosing.
Our MCC and tartaric acid spheres production benefits from the requirements of manufacturing GMP Excipients.